Medical information
12 articles shown
When Green or Yellow Vomiting Won't Stop Despite Anti-Nausea Medicine — Understanding Bile Vomiting and Spotting the Warning Signs of Bowel Obstruction in Peritoneal Metastasis
In peritoneal metastasis from stomach cancer, persistent green or yellow (bile) vomiting despite antiemetics can signal a bowel obstruction; here are the warning signs to watch, how to manage dehydration, and when to call your care team.
When 'Inoperable' Liver Metastases Become Operable: Understanding Conversion Therapy in Colorectal Cancer
Liver metastases from colorectal cancer that are 'inoperable' at first can sometimes become operable after chemotherapy shrinks them—an approach called conversion therapy. This piece explains how resectability is judged, how to read tumor markers as a trend, and why follow-up continues after surgery.
When Nausea Keeps Coming During Chemo or Radiation — Anti-Nausea Medicines Aren't One-Size-Fits-All, and Can Be Switched or Combined
Explains delayed nausea that rises the day after chemo or radiation, and why antiemetics span several drug classes and forms with responses that differ between people. Encourages patients not to simply endure a medicine that isn't working but to report specifics so the team can switch or combine drugs.
When You Can Only 'Watch' the Drinks at a Gathering — Understanding Alcohol and Cancer Treatment, and Ways to Protect Yourself
When drinks are offered at a gathering during or after treatment, this piece explains the link between alcohol and cancer care and offers calm, practical ways to pass on a glass without strain.
Told You're in Remission but Not 'Cured'? Understanding Micrometastasis and Why Follow-Up Continues
Remission means no cancer is visible on tests, which is not the same as a cure. This piece explains micrometastasis and why regular follow-up continues after treatment.
When Chemo Is 'Weekly for Three Weeks, Then a Week Off' — Understanding Why Treatment Runs in Cycles and What the Rest Week Does
A plain-language look at why chemotherapy runs in cycles, what the rest week does for recovery and blood counts like neutrophils, how single-drug and combination regimens differ, and which side effects to watch for and report.
Moving to Third-Line Treatment in Metastatic Colorectal Cancer: Understanding Oral Chemotherapy (Lonsurf) and Why Later Treatments Are Used in Sequence
How later lines of therapy work in metastatic colorectal cancer, what oral chemotherapy such as Lonsurf is, why treatments are given in a planned sequence, and how to seek a second opinion.
When you hear the unfamiliar diagnosis 'appendiceal cancer' — how it differs from common bowel cancer and why mucinous tumors spread across the peritoneum
A plain-language explainer on rare appendiceal cancer, how mucinous tumors spread across the peritoneum (pseudomyxoma peritonei), why cell grade shapes the outlook, and specialized treatments such as cytoreductive surgery and HIPEC.
Why So Young? — How Cancer in Adolescents and Young Adults (AYA) Differs From Older-Adult Cancer, and Why It Is Often Diagnosed Late
AYA cancer, diagnosed roughly between ages 15 and 39, can differ from older-adult cancer in which cancers occur, how the body responds, and the life challenges involved. This piece explains why it is often diagnosed late, which signals deserve a check, and why fertility preservation and emotional care belong in the conversation.
Facing a GIST diagnosis: how this tumor differs from common stomach and bowel cancers, and why gene testing helps predict response to targeted therapy
A gastrointestinal stromal tumor (GIST) behaves differently from common stomach and bowel cancers. When surgery is difficult, targeted therapy such as imatinib may come first, and response can depend on gene changes like KIT or PDGFRA — so mutation testing helps guide treatment. Effect is tracked by comparing tumor size on CT rather than by a single blood marker.
Does a Sudden Spike in a Tumor Marker Mean the Drug Has Stopped Working? Why One Number Is Not Enough, and How Imaging Confirms It
A sudden rise in a tumor marker during chemotherapy often triggers fear of resistance, but markers are only reference signals and one value cannot confirm that a drug has stopped working. This piece explains what drug resistance means, why marker levels fluctuate, and how CT or MRI imaging is used to assess treatment response.
Why Your Thyroid Hormone Dose Keeps Getting Readjusted After Thyroid Surgery — Managing Levels Through Pregnancy, Stress, and Everyday Changes
Thyroid hormone medication (levothyroxine) taken after thyroid removal or low thyroid function needs periodic dose adjustment. This article explains why levels change, how pregnancy raises the requirement, and the basics of taking and monitoring the medicine.